Skip to Content
You are currently on the new version of our website. Access the old version .
BiomedicinesBiomedicines
  • Article
  • Open Access

13 May 2021

20 Pages

Multi-Functional MPT Protein as a Therapeutic Agent against Mycobacterium tuberculosis

,
,
,
,
,
,
,
,
…
1
Department of Bionano Technology, Hanyang University, Seoul 04673, Korea
2
Institute of Natural Science & Technology, Hanyang University, Ansan 15588, Korea
3
Center for Bionano Intelligence Education and Research, Ansan 15588, Korea
4
Department of Molecular and Life Science, Hanyang University, Ansan 15588, Korea

Abstract

Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis (TB), avoids the host immune system through its virulence factors. MPT63 and MPT64 are the virulence factors secreted by MTB which regulate host proteins for the survival and proliferation of MTB in the host. Here, we found that MPT63 bound directly with TBK1 and p47phox, whereas MPT64 interacted with TBK1 and HK2. We constructed a MPT63/64-derived multifunctional recombinant protein (rMPT) that was able to interact with TBK1, p47phox, or HK2. rMPT was shown to regulate IFN-β levels and increase inflammation and concentration of reactive oxygen species (ROS), while targeting macrophages and killing MTB, both in vitro and in vivo. Furthermore, the identification of the role of rMPT against MTB was achieved via vaccination in a mouse model. Taken together, we here present rMPT, which, by regulating important immune signaling systems, can be considered an effective vaccine or therapeutic agent against MTB.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.